We had the privilege of interviewing Dr. Matsui and Dr. Feld, who offered insights into the considerations for joining a clinical trial for MDS treatment.
Doctors usually recommend joining a clinical trial for patients who experience symptoms from MDS, which is the case for the majority of MDS patients. MDS patients are classified according to the risk of their disease progressing into acute leukemia. The therapies administered, treatment goals, and, therefore, the patient’s eligibility for a clinical trial will be adapted to that risk:
Since treatment options available for MDS are continuously expanding, clinical trials might always be a good option to explore. The goal is to individualize the therapy according to the patient’s genetics, symptoms, and overall health. By participating in clinical trials, the options for finding out what works best will be more accurate, and the outcomes will improve over time.
Educated and empowered patients who understand all their treatment options often have better outcomes. HealthTree University is the first and only free comprehensive curriculum for patients and caregivers. If you want to keep reading and learn more about MDS, create a free account to gain exclusive access. There, you can watch our newest unreleased videos and easily explore topics through our organized courses. Visit HealthTree University and become an empowered patient today!
We had the privilege of interviewing Dr. Matsui and Dr. Feld, who offered insights into the considerations for joining a clinical trial for MDS treatment.
Doctors usually recommend joining a clinical trial for patients who experience symptoms from MDS, which is the case for the majority of MDS patients. MDS patients are classified according to the risk of their disease progressing into acute leukemia. The therapies administered, treatment goals, and, therefore, the patient’s eligibility for a clinical trial will be adapted to that risk:
Since treatment options available for MDS are continuously expanding, clinical trials might always be a good option to explore. The goal is to individualize the therapy according to the patient’s genetics, symptoms, and overall health. By participating in clinical trials, the options for finding out what works best will be more accurate, and the outcomes will improve over time.
Educated and empowered patients who understand all their treatment options often have better outcomes. HealthTree University is the first and only free comprehensive curriculum for patients and caregivers. If you want to keep reading and learn more about MDS, create a free account to gain exclusive access. There, you can watch our newest unreleased videos and easily explore topics through our organized courses. Visit HealthTree University and become an empowered patient today!
about the author
Jimena Vicencio
Jimena is an International Medical Graduate and a member of the HealthTree Writing team. She has a passion for languages and is currently learning Japanese. In her free time, she loves playing with her cats. Jimena is also pursuing a bachelor's degree in journalism.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.